VelosBio, Inc.
Overview
VelosBio, Inc. is a biotechnology company focused on developing innovative antibody-drug conjugates for the treatment of cancer. As a subsidiary of Merck & Co., Inc., VelosBio leverages cutting-edge science to advance its pipeline of targeted therapies.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to VelosBio, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.